Zydus Lifesciences gets USFDA nod for Pulmonary Arterial Hypertension drug Selexipag Ruchika Sharma6 May 2022 3:03 PM ISTThe drug will be manufactured at group’s formulation facility at SEZ, Ahmedabad.
Zydus gets USFDA Prior Approval Supplement (PAS) approval for Mycophenolate Mofetil for Injection USP MD Bureau21 March 2022 4:41 PM ISTThe injection will be manufactured at the groups injectables manufacturing facility at Jarod near Vadodara in Gujarat.
Zydus Lifesciences gets USFDA nod for Colestipol Hydrochloride Tablets MD Bureau16 March 2022 3:41 PM ISTColestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and LDL-C in patients with...
Zydus gets DCGI nod for Oxemia MD Bureau8 March 2022 2:05 PM ISTThe clinical development programme of Desidustat was one of the largest trials of its kind in India for Anemia in CKD patients, conducted in over...
Zydus to launch Desidustat breakthrough treatment for Anemia in CKD patients under brand name Oxemia MD Bureau7 March 2022 12:04 PM ISTOxemia is an oral, small molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor.
Health Bulletin 25/February/2022 Roshni Dhar25 Feb 2022 4:26 PM ISTHere are Health stories of the dayNMC releases TEQ qualifications in Medical Institutions Regulations 2022Comprehensively laying down out the...
Cadila Healthcare is now Zydus Lifesciences Ruchika Sharma24 Feb 2022 6:08 PM ISTNew Delhi: The Zydus group announced its new brand identity with the listed entity of the group Cadila Healthcare Ltd. to be known as Zydus...
USFDA nod to Zydus to market generic version of Vigabatrin Dr. Divya Colin21 Jan 2022 4:02 PM ISTThe approval by the US Food and Drug Administration is for Vigabatrin tablets of 500 mg strength, Cadila Healthcare said in a regulatory filing.
Zydus allowed to conduct Phase 2 trial of ZYIL1 in CAPS patients in Australia Ruchika Sharma14 Dec 2021 1:29 PM ISTAhmedabad: Global pharmaceutical company, Zydus has announced that it has received permission to initiate the Phase II (a) clinical study of its...
Zydus Cadila Saroglitazar Mg gets Orphan Drug Designation from EMA Ruchika Sharma22 July 2021 3:17 PM ISTSaroglitazar Mg is a potent and selective peroxisome proliferator-activated receptor alpha and gamma dual agonist.
IPCA Labs invests Rs 25 crore In ABCD Technologies Medical Dialogues Team1 May 2021 4:56 PM ISTMumbai: Drugmaker IPCA Laboratories has recently announced that the company will be investing Rs 25 crore in ABCD Technologies.As per its recent...
Zydus Cadila division settles patent litigation with Adamas Pharma over dyskinesia drug Gocovri Farhat Nasim17 Feb 2021 6:23 PM ISTNew Delhi: The US generic drug division of Zydus Cadila Healthcare, Zydus Pharmaceuticals (USA) Inc., and Zydus Worldwide DMCC recently entered into a...
